pmid	doi	year	title	Hugo_Symbol
27867987	10.21037/atm.2016.10.20	2022	Modifying therapy in patients with advanced Hodgkin's lymphoma by integrating early metabolic response by interim PET-CT.	ATM
30279714		2022	A Novel Splice Site Mutation of the ATM Gene Associated with Ataxia Telangiectasia.	ATM
30538965	10.2147/ITT.S179656	2022	Alteration of gene expression profile in CD3<sup>+</sup> T-cells after downregulating MALT1.	ATM
31317002	10.21037/atm.2018.08.05	2022	Machine learning for semi-automated classification of glioblastoma, brain metastasis and central nervous system lymphoma using magnetic resonance advanced imaging.	ATM
31355228	10.21037/atm.2019.05.28	2022	Prognostic significance of the <i>PANK</i> family expression in acute myeloid leukemia.	ATM
31475177	10.21037/atm.2019.06.29	2022	Deep convolutional neural network Inception-v3 model for differential diagnosing of lymph node in cytological images: a pilot study.	ATM
31475178	10.21037/atm.2019.06.32	2022	Primary colorectal lymphoma: computed tomography and double-contrast barium enema examination findings with histopathological correlation in 19 patients.	ATM
31475186	10.21037/atm.2019.06.53	2022	Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma.	ATM
31555687	10.21037/atm.2019.07.17	2022	Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.	ATM
32042774	10.21037/atm.2019.11.71	2022	Upregulated <i>miR-155</i> inhibits inflammatory response induced by <i>C. albicans</i> in human monocytes derived dendritic cells via targeting p65 and BCL-10.	ATM
32395536	10.21037/atm.2020.02.86	2022	The role of inflammation in a rat model of chronic thromboembolic pulmonary hypertension induced by carrageenan.	ATM
32566584	10.21037/atm-20-3768	2022	Beta carotene protects H9c2 cardiomyocytes from advanced glycation end product-induced endoplasmic reticulum stress, apoptosis, and autophagy via the PI3K/Akt/mTOR signaling pathway.	ATM
32617308	10.21037/atm-19-4324	2022	Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma.	ATM
32617310	10.21037/atm-20-3875	2022	Retrospective analysis of 1,641 cases of classic fever of unknown origin.	ATM
32695399	10.1186/s40364-020-00205-4	2022	Plasma circulating tumor DNA assessment reveals <i>KMT2D</i> as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.	ATM
33145267	10.21037/atm-20-4363	2022	Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study.	ATM
33209875	10.21037/atm-20-5741	2022	Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis.	ATM
33209887	10.21037/atm-20-6619	2022	Anaplastic lymphoma kinase rearrangement may increase the incidence of venous thromboembolism by increasing tissue factor expression in advanced lung adenocarcinoma.	ATM
33209900	10.21037/atm-20-6598	2022	Peroxiredoxin 6 overexpression regulates adriamycin-induced myocardial injury, oxidative stress and immune response in rats.	ATM
33490165	10.21037/atm-20-7365	2022	Long non-coding RNA nuclear paraspeckle assembly transcript 1 protects human lens epithelial cells against H<sub>2</sub>O<sub>2</sub> stimuli through the nuclear factor kappa b/p65 and p38/mitogen-activated protein kinase axis.	ATM
33569430	10.21037/atm-20-7574	2022	Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity.	ATM
33708955	10.21037/atm-20-5308	2022	B7-H6 is a new potential biomarker and therapeutic target of T-lymphoblastic lymphoma.	ATM
34074205	10.1080/15548627.2021.1936932	2022	Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance.	ATM
34128135	10.1007/s10689-021-00266-w	2022	The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.	ATM
34150491	10.1016/j.lrr.2021.100255	2022	Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma.	ATM
34164483	10.21037/atm-21-1748	2022	Survival trends for extranodal NK/T-cell lymphoma, nasal type from different anatomical sites: a population-based study.	ATM
34164486	10.21037/atm-21-1614	2022	MicroRNA-664a-3p inhibits the proliferation of ovarian granulosa cells in polycystic ovary syndrome and promotes apoptosis by targeting BCL2A1.	ATM
34226971	10.1007/s00428-021-03148-9	2022	Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.	ATM
34277771	10.21037/atm-21-2360	2022	Norcantharidin triggers apoptotic cell death in non-small cell lung cancer via a mitophagy-mediated autophagy pathway.	ATM
34277781	10.21037/atm-21-2574	2022	A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway.	ATM
34277784	10.21037/atm-21-2481	2022	<i>In vitro</i> and <i>in vivo</i> study on prevention of myocardial ischemic injury by taurine.	ATM
34277785	10.21037/atm-21-2256	2022	Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces.	ATM
34277809	10.21037/atm-21-2790	2022	<sup>18</sup>F-fluorodeoxyglucose positron emission tomography-based prediction for splenectomy in patients with suspected splenic lymphoma.	ATM
34277814	10.21037/atm-21-2769	2022	Outcomes of switching from crizotinib to alectinib in patients with advanced non-small cell lung cancer with anaplastic lymphoma kinase fusion.	ATM
34277836	10.21037/atm-20-5546	2022	CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges.	ATM
34277837	10.21037/atm-20-6833	2022	Immune checkpoint inhibitors in lymphoma: challenges and opportunities.	ATM
34319003	10.1002/cnr2.1524	2022	Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma.	ATM
34350237	10.21037/atm-20-7900	2022	Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay.	ATM
34350246	10.21037/atm-21-2570	2022	LncRNA-GAS5 promotes spinal cord repair and the inhibition of neuronal apoptosis via the transplantation of 3D printed scaffold loaded with induced pluripotent stem cell-derived neural stem cells.	ATM
34422956	10.21037/atm-21-1754	2022	Characterization of comprehensive dynamic epigenetic changes during human primary Sjögren's syndrome progression.	ATM
34422967	10.21037/atm-21-753	2022	Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis.	ATM
34430607	10.21037/atm-21-3199	2022	The potential differential diagnosis value and clinical significance of CD35 expression in B-chronic lymphoproliferative disorders.	ATM
34430619	10.21037/atm-21-3525	2022	Phase II study of sequential chemoradiotherapy with L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide (DICE-L) in the early stage of extranodal natural killer (NK)/T-cell lymphoma.	ATM
34532394	10.21037/atm-21-3233	2022	Ozone induces BEL7402 cell apoptosis by increasing reactive oxygen species production and activating JNK.	ATM
34532474	10.21037/atm-21-3924	2022	A bibliometric analysis of the research on hematological tumor microenvironment.	ATM
34733912	10.21037/atm-21-1951	2022	Inhibit inflammation and apoptosis of pyrroloquinoline on spinal cord injury in rat.	ATM
34734014	10.21037/atm-21-4185	2022	The expression of heat shock protein A12B (HSPA12B) in non-Hodgkin's lymphomas.	ATM
34790748	10.21037/atm-21-4761	2022	Development and validation of prognostic scoring in primary intestinal diffuse large B-cell lymphoma: a single-institution study of 184 patients.	ATM
34790798	10.21037/atm-21-5350	2022	Shenqi Lixin Decoction improves cardiac function in rats with adriamycin-induced heart failure through modulation of PGC-1α and mitochondrial apoptosis pathway.	ATM
34882582	10.1172/JCI153283	2022	Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.	ATM
34886743	10.1080/15257770.2021.2013500	2022	Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell lines.	ATM
34898335	10.1080/10428194.2021.2010061	2022	Molecular characterization of Novel <i>ATM</i> fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia.	ATM
34908084	10.1039/d1lc00846c	2022	The non-contact-based determination of the membrane permeability to water and dimethyl sulfoxide of cells virtually trapped in a self-induced micro-vortex.	ATM
34988210	10.21037/atm-21-5975	2022	Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism.	ATM
35035775	10.18632/oncotarget.28177	2022	GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells.	ATM
35047863	10.1016/j.xhgg.2021.100078	2022	A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk.	ATM
35071438	10.21037/atm-21-6516	2022	Mitosis-related gene <i>CENP-U</i> as a potential biomarker in malignancy.	ATM
35071463	10.21037/atm-21-6019	2022	Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study.	ATM
35126471	10.3389/fgene.2021.815679	2022	Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma.	ATM
35280362	10.21037/atm-22-412	2022	Genomic landscape and prognosis of patients with <i>TP53</i>-mutated non-small cell lung cancer.	ATM
35280407	10.21037/atm-22-91	2022	Mechanism of protective role of miR-874-3p in intervertebral disc degeneration.	ATM
35280429	10.21037/atm-21-6710	2022	Knockdown of <i>lncRNA AL928768.3</i> inhibits multiple myeloma cell proliferation by inducing cell cycle arrest in G0/G1 phase.	ATM
35282073	10.21037/atm-21-6589	2022	Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry.	ATM
35284771	10.1210/jendso/bvac026	2022	Thyroid and Breast Cancer in 2 Sisters With Monoallelic Mutations in the Ataxia Telangiectasia Mutated (<i>ATM</i>) Gene.	ATM
35353542	10.1126/scitranslmed.abc7480	2022	Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells.	ATM
35409194	10.3390/ijms23073834	2022	Targeting the DNA Damage Response to Increase Anthracycline-Based Chemotherapy Cytotoxicity in T-Cell Lymphoma.	ATM
35433977	10.21037/atm-22-1159	2022	Copanlisib plus rituximab combination therapy <i>vs.</i> rituximab monotherapy for relapsed indolent non-Hodgkin lymphoma: a cost-effectiveness analysis.	ATM
35433994	10.21037/atm-22-20	2022	Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma.	ATM
35434008	10.21037/atm-22-580	2022	Recent advances in bronchial thermoplasty for severe asthma: a narrative review.	ATM
35434046	10.21037/atm-22-711	2022	The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion-induced lung injury.	ATM
35439335	10.1002/hon.3007	2022	The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.	ATM
35445145	10.1016/j.jdcr.2022.02.032	2022	Ataxia-telangiectasia mutated (ATM) gene mutation in a patient with primary cutaneous marginal zone lymphoma.	ATM
35571440	10.21037/atm-22-894	2022	Long non-coding RNA MEG3 regulates the progress of osteoarthritis by regulating the miR-34a/Klotho axis.	ATM
35644065	10.1016/j.cancergen.2022.05.039	2022	Homozygous ATM mutation due to germline uniparental isodisomy in patient with T acute lymphoblastic leukemia and hepatosplenic T-cell lymphoma.	ATM
35663228	10.1016/j.omto.2022.04.012	2022	Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime.	ATM
35674998	10.1007/s11899-022-00663-7	2022	Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.	ATM
35687490	10.1182/bloodadvances.2021006654	2022	Genomic characterization of lymphomas in patients with inborn errors of immunity.	ATM
35708139	10.3324/haematol.2022.281226	2022	Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.	ATM
35722364	10.21037/atm-22-2233	2022	Mitochondria-specific peptide amphiphiles induce mitochondrial dysfunction and peripheral T-cell lymphomas (PTCL) damage.	ATM
35722399	10.21037/atm-22-1549	2022	Myocardial protection of propofol on apoptosis induced by anthracycline by PI3K/AKT/Bcl-2 pathway in rats.	ATM
35761419	10.1186/s40164-022-00292-z	2022	Targeting metabolic reprogramming in chronic lymphocytic leukemia.	ATM
35787399	10.1016/j.jid.2022.06.005	2022	The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion.	ATM
35829664	10.1111/bjh.18352	2022	Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.	ATM
35835912	10.1038/s41588-022-01121-z	2022	Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.	ATM
35845484	10.21037/atm-22-2780	2022	WX-0593 combined with an epithelial growth factor receptor (EGFR) monoclonal antibody in the treatment of xenograft tumors carrying triple <i>EGFR</i> mutations.	ATM
35845500	10.21037/atm-22-394	2022	Bortezomib, epirubicin, and dexamethasone (PAD) results in superior free-progression survival compared to bortezomib, cyclophosphamide, and dexamethasone (VCD) treatment in non-transplantation newly diagnosed multiple myeloma patients aged between 50 to 65: a retrospective single-center analysis in non-transplant patients.	ATM
35845509	10.21037/atm-22-2672	2022	Protective effects of muscone on traumatic spinal cord injury in rats.	ATM
35881112	10.1084/jem.20220214	2022	Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma.	ATM
35965785	10.21037/atm-22-3027	2022	The m<sup>6</sup>A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m<sup>6</sup>A modification of catenin beta 1.	ATM
35965796	10.21037/atm-22-3423	2022	Strengthening of antitumor effects in breast cancer from a novel B7-H4- and CD3-targeting bispecific antibody by an oncolytic virus.	ATM
36029002	10.1111/bjh.18419	2022	Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.	ATM
36034985	10.21037/atm-22-302	2022	Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China.	ATM
36065483	10.1111/cas.15522	2022	Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk.	ATM
30941227	10.1155/2019/4915086	2021	Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy.	ATM
31028364	10.1038/s41379-019-0279-8	2021	Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.	ATM
31743320	10.1097/MPH.0000000000001672	2021	Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell Leukemia.	ATM
31885322	10.1080/15384101.2019.1706903	2021	The double dealing of cyclin D1.	ATM
32029507	10.3324/haematol.2019.234385	2021	Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma.	ATM
32220941	10.1136/jclinpath-2020-206476	2021	Abnormal expression of p-ATM/CHK2 in nasal extranodal NK/T cell lymphoma, nasal type, is correlated with poor prognosis.	ATM
32277542	10.1002/gcc.22849	2021	Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.	ATM
32321318	10.1080/13543784.2020.1760245	2021	Novel agents for mantle cell lymphoma: molecular rational and clinical data.	ATM
32469082	10.1002/cncr.32866	2021	Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.	ATM
32517809	10.1186/s13046-020-01597-9	2021	A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe.	ATM
32584970	10.1182/blood.2020005289	2021	Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.	ATM
32598477	10.1182/bloodadvances.2019001350	2021	Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.	ATM
32601814	10.1007/s11864-020-00763-7	2021	Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma.	ATM
32653773	10.1016/j.ejca.2020.05.010	2021	Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.	ATM
32751805	10.3390/cancers12082120	2021	Concurrent <i>TP53</i> and <i>CDKN2A</i> Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy.	ATM
32908627	10.1155/2020/2647670	2021	A Novel Oral Astaxanthin Nanoemulsion from <i>Haematococcus pluvialis</i> Induces Apoptosis in Lung Metastatic Melanoma.	ATM
32996079	10.1007/s11010-020-03917-1	2021	Activation of ATM kinase by ROS generated during ionophore-induced mitophagy in human T and B cell malignancies.	ATM
33066395	10.3390/cells9102287	2021	Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma.	ATM
33257682	10.1038/s41419-020-03231-0	2021	ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells.	ATM
33273545	10.1038/s41598-020-78193-6	2021	SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma.	ATM
33484281	10.1007/s00109-020-02020-8	2021	3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.	ATM
33490066	10.3389/fcell.2020.599048	2021	ATM Kinase-Dependent Regulation of Autophagy: A Key Player in Senescence?	ATM
33536256	10.4049/jimmunol.2000967	2021	FATC Domain Deletion Compromises ATM Protein Stability, Blocks Lymphocyte Development, and Promotes Lymphomagenesis.	ATM
33541390	10.1186/s13039-020-00526-x	2021	Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?	ATM
33585229	10.3389/fonc.2020.609409	2021	The Effect of <i>SF3B1</i> Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer.	ATM
33683983	10.1177/1093526621999022	2021	EBV-Positive Plasmacytomas Involving a Nasopharyngeal Angiofibroma in an Adolescent.	ATM
33750258	10.1080/0284186X.2021.1900908	2021	Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on <i>BCR-ABL1</i>-like subtype.	ATM
33809641	10.3390/cancers13061340	2021	Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms.	ATM
33842642	10.21037/atm-20-6933	2021	Reporting of coronavirus disease 2019 prognostic models: the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis statement.	ATM
33987281	10.21037/atm-20-4307	2021	Bronchoalveolar lavage-detected SARS-CoV-2 infection in presence of serial negative nasopharyngeal swabs: a case report.	ATM
34024245	10.1080/07420528.2021.1928157	2021	Circadian rhythm genes in cancer: insight into their functions and regulation involving noncoding RNAs.	ATM
34080947	10.1080/10428194.2021.1933480	2021	Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets.	ATM
34174847	10.1186/s12885-021-08475-3	2021	Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma.	ATM
34183044	10.1186/s13023-021-01904-3	2021	Gene expression analysis in EBV-infected ataxia-telangiectasia cell lines by RNA-sequencing reveals protein synthesis defect and immune abnormalities.	ATM
34199532	10.3390/children8060469	2021	Germline Mutations Including the Rare Pathogenic Variant c.3206delC in the <i>ATM</i> Gene Cause Ataxia Teleangiectasia-Associated Primary Central Nervous System Lymphoma.	ATM
34256839	10.1186/s40164-021-00232-3	2021	Progress in molecular feature of smoldering mantle cell lymphoma.	ATM
34267759	10.3389/fimmu.2021.693897	2021	Survival and Functional Immune Reconstitution After Haploidentical Stem Cell Transplantation in <i>Atm</i>-Deficient Mice.	ATM
34268436	10.21037/atm-20-6162	2021	Applications of artificial intelligence in oncologic <sup>18</sup>F-FDG PET/CT imaging: a systematic review.	ATM
34424493	10.1007/s12185-021-03203-w	2021	Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia-telangiectasia caused by novel compound heterozygous variants in ATM.	ATM
34506616	10.1371/journal.pone.0257353	2021	Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).	ATM
34521752	10.1073/pnas.2105440118	2021	DNA damage-induced phosphorylation of CtIP at a conserved ATM/ATR site T855 promotes lymphomagenesis in mice.	ATM
34557402	10.3389/fonc.2021.638757	2021	Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma.	ATM
34734040	10.21037/atm-21-3853	2021	Clinical pharmacist participation in selecting and dosing targeted drugs for a patient with ALK-positive non-small cell lung cancer: a case report.	ATM
34805369	10.21037/atm-21-3923	2021	Successful targeting of the <i>NRG1</i> fusion reveals durable response to afatinib in lung adenocarcinoma: a case report.	ATM
28251118	10.21037/atm.2016.12.25	2020	Optimizing antiviral agents for hepatitis B management in malignant lymphomas.	ATM
28280620	10.21037/jgo.2017.01.14	2020	Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.	ATM
28344752	10.4239/wjd.v8.i3.97	2020	Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance.	ATM
28361070	10.21037/atm.2017.03.08	2020	Primary psoas sarcoma causing malignant psoas syndrome: favourable response to radiotherapy.	ATM
28487787	10.1155/2017/5083463	2020	EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in <i>ASXL1</i>, <i>BCOR</i>, <i>CDKN2A</i>, <i>NF1</i>, and <i>TP53</i>.	ATM
28693235	10.3892/ol.2017.6219	2020	Japanese apricot extract (MK615) potentiates bendamustine-induced apoptosis via impairment of the DNA damage response in lymphoma cells.	ATM
29057231	10.21037/atm.2017.08.29	2020	Prioritizing molecular markers to test for in the initial workup of advanced non-small cell lung cancer: wants versus needs.	ATM
29118858	10.4103/atm.ATM_21_17	2020	Characteristics and predictors of mortality of patients with hematologic malignancies requiring invasive mechanical ventilation.	ATM
29285493	10.21037/atm.2017.09.05	2020	Alectinib in untreated anaplastic lymphoma kinase-positive non-small cell lung cancer.	ATM
29434894	10.3892/ol.2017.7500	2020	Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.	ATM
29616088	10.3892/ol.2018.8014	2020	Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model.	ATM
29616191	10.3389/fonc.2018.00073	2020	Ataxia-Telangiectasia Mutated Kinase in the Control of Oxidative Stress, Mitochondria, and Autophagy in Cancer: A Maestro With a Large Orchestra.	ATM
29675060	10.4103/atm.ATM_317_17	2020	Utility and safety of endobronchial ultrasound-guided transbronchial needle aspiration in patients with mediastinal and hilar lymphadenopathy: Western region experience.	ATM
29862230	10.21037/atm.2017.11.34	2020	Treating ALK-positive non-small cell lung cancer.	ATM
29911108	10.21037/atm.2018.05.02	2020	Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.	ATM
29911112	10.21037/atm.2018.05.05	2020	Translational research and application of basic biology to clinical trial development in GI cancers.	ATM
30023399	10.21037/atm.2018.05.36	2020	Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.	ATM
30023400	10.21037/atm.2018.05.39	2020	Revolutionary changes in salvage treatment for Hodgkin lymphoma: toward a chemotherapy-free future.	ATM
30023401	10.21037/atm.2018.05.40	2020	Is there a place for the combination of brentuximab vedotin and bendamustine in treatment of patients with relapsed/refractory Hodgkin lymphoma?	ATM
30151355	10.3389/fonc.2018.00317	2020	T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways.	ATM
30596074	10.21037/atm.2018.10.24	2020	Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression.	ATM
30618266	10.1089/AID.2018.0196	2020	Intrinsically Disordered Human T Lymphotropic Virus Type 1 p30 Protein: Experimental and Computational Evidence.	ATM
30626249	10.1080/10428194.2018.1542144	2020	ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.	ATM
30854058	10.3892/ol.2019.9900	2020	Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis.	ATM
30931099	10.1039/c8tx00281a	2020	Fresh and ozonized black carbon promoted DNA damage and repair responses in A549 cells.	ATM
30940905	10.1038/s41375-019-0458-0	2020	Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia.	ATM
30975914	10.3324/haematol.2018.203430	2020	Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells.	ATM
31019956	10.21037/atm.2019.01.24	2020	Ceritinib-related interstitial lung disease improving after treatment cessation without recurrence under either crizotinib or brigatinib: a case report.	ATM
31025879	10.1089/cbr.2019.2787	2020	Inhibition of SKP2 Activity Impaired ATM-Mediated DNA Repair and Enhanced Sensitivity of Cisplatin-Resistant Mantle Cell Lymphoma Cells.	ATM
31064869	10.1158/1535-7163.MCT-18-0919	2020	DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas.	ATM
31132650	10.1016/j.anndiagpath.2019.05.004	2020	TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.	ATM
31279905	10.1016/j.jhep.2019.06.029	2020	TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.	ATM
31544558	10.1177/1066896919876704	2020	Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.	ATM
31552178	10.3389/fonc.2019.00853	2020	Cinobufagin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis in Malignant Melanoma Cells.	ATM
31565865	10.1111/jcmm.14685	2020	SMG1 heterozygosity exacerbates haematopoietic cancer development in Atm null mice by increasing persistent DNA damage and oxidative stress.	ATM
31690822	10.1038/s41375-019-0618-2	2020	ATM activity in T cells is critical for immune surveillance of lymphoma in vivo.	ATM
31827702	10.1155/2019/7989276	2020	Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells.	ATM
31850668	10.1002/pbc.28126	2020	EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects.	ATM
32012328	10.1002/hon.2718	2020	High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.	ATM
32109421	10.1016/j.ajhg.2020.02.006	2020	Genome-wide Association Analysis in Humans Links Nucleotide Metabolism to Leukocyte Telomere Length.	ATM
32173361	10.1016/j.exphem.2020.03.001	2020	Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.	ATM
32239765	10.1002/ajh.25796	2020	Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.	ATM
32311893	10.3760/cma.j.issn.0253-2727.2020.03.008	2020	[The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion].	ATM
32548172	10.12998/wjcc.v8.i11.2387	2020	Ataxia-telangiectasia complicated with Hodgkin's lymphoma: A case report.	ATM
32647695	10.21037/atm-20-3927	2020	Perioperative crizotinib in a patient with stage IIIB ALK-positive non-small cell lung cancer: a case report.	ATM
32770099	10.1038/s41598-020-70310-9	2020	Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study.	ATM
32796077	10.1128/JVI.01179-20	2020	A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.	ATM
32892059	10.1016/j.ctrv.2020.102090	2020	Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences.	ATM
32953835	10.21037/atm.2020.04.06	2020	Checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?	ATM
32973968	10.18632/oncotarget.27723	2020	ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest.	ATM
33142696	10.3390/cancers12113207	2020	Bone Marrow Transplantation as Therapy for Ataxia-Telangiectasia: A Systematic Review.	ATM
33145331	10.21037/atm.2020.04.54	2020	Pembrolizumab (and friends) in pediatric malignancies: should we consider Hodgkin lymphoma a world of its own?	ATM
33313219	10.21037/atm-2020-40	2020	Erratum to checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?	ATM
27823642	10.1016/j.critrevonc.2016.08.008	2019	ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma.	ATM
28643365	10.1111/bjh.14793	2019	A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.	ATM
28885618	10.1038/cdd.2017.138	2019	Loss of BIM augments resistance of ATM-deficient thymocytes to DNA damage-induced apoptosis but does not accelerate lymphoma development.	ATM
29113297	10.18632/oncotarget.17956	2019	Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2 complex.	ATM
29249192	10.1080/10428194.2017.1413188	2019	DNA damage response-initiated cytokine secretion in bone marrow stromal cells promotes chemoresistance of myeloma cells.	ATM
29352223	10.1038/s41419-017-0087-3	2019	ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.	ATM
29415938	10.11406/rinketsu.59.51	2019	[Acquisition of IgH/CCND1 translocation during the natural disease course in a patient with chronic lymphocytic leukemia].	ATM
29423093	10.18632/oncotarget.23386	2019	Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells.	ATM
29492593	10.1007/s00251-018-1056-4	2019	Novel biallelic ATM mutations coexist with a mosaic form of triple X syndrome in an 11-year-old girl at remission after T cell acute leukemia.	ATM
29504068	10.1007/s10637-017-0552-y	2019	Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.	ATM
29564828	10.1007/978-1-4939-7780-2_15	2019	Genes, Proteins, and Biological Pathways Preventing Chromothripsis.	ATM
29702521	10.1097/MOH.0000000000000433	2019	DNA damage pathways and B-cell lymphomagenesis.	ATM
29735551	10.1158/0008-5472.CAN-17-4004	2019	Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.	ATM
29755111	10.1038/s41417-018-0022-5	2019	Genomic landscape and prognostic analysis of mantle cell lymphoma.	ATM
29769262	10.1182/blood-2018-03-838136	2019	A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.	ATM
30038380	10.1038/s41375-018-0215-9	2019	Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.	ATM
30175400	10.1111/bjh.15567	2019	Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.	ATM
30401751	10.1182/bloodadvances.2018022962	2019	Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia.	ATM
30455436	10.1038/s41591-018-0243-z	2019	Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma.	ATM
30522172	10.3760/cma.j.issn.0529-5807.2018.12.005	2019	[Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].	ATM
30569095	10.3892/mmr.2018.9745	2019	Theaflavins prevent cartilage degeneration via AKT/FOXO3 signaling in vitro.	ATM
30578714	10.1002/gcc.22726	2019	Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.	ATM
30594162	10.1186/s12885-018-5205-9	2019	miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.	ATM
30662441	10.3389/fimmu.2018.03060	2019	Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?	ATM
30664664	10.1038/s41375-018-0355-y	2019	Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells.	ATM
30813936	10.1186/s12885-019-5377-y	2019	Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.	ATM
31473630	10.1136/jclinpath-2019-205895	2019	Somatic <i>SF3B1</i> mutations in myelodysplastic syndrome with ring sideroblasts and chronic lymphocytic leukaemia.	ATM
27102345	10.1038/modpathol.2016.79	2018	Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.	ATM
27121112	10.3109/10428194.2016.1173212	2018	Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.	ATM
27224912	10.18632/oncotarget.9500	2018	Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.	ATM
27268868	10.1080/10428194.2016.1187276	2018	Ability to downregulate the level of cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway.	ATM
27449094	10.18632/oncotarget.10716	2018	Gene mutations and actionable genetic lesions in mantle cell lymphoma.	ATM
27545008	10.1080/10428194.2016.1213837	2018	Rapid detection of ATM/p53 function with p27Kip FACS analysis: a novel diagnostic tool for chronic lympocytic leukemia?	ATM
27626308	10.18632/oncotarget.11904	2018	The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma.	ATM
27769042	10.18632/oncotarget.12705	2018	ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.	ATM
27793024	10.18632/oncotarget.12908	2018	Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice.	ATM
28123174	10.1038/jhg.2017.6	2018	New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation.	ATM
28284458	10.1016/j.blre.2017.03.001	2018	p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell.	ATM
28340172	10.1093/neuonc/now300	2018	Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.	ATM
28351340	10.1089/thy.2016.0254	2018	Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.	ATM
28450576	10.1182/blood-2017-02-766782	2018	De novo Richter transformation.	ATM
28559149	10.1016/j.clml.2017.04.001	2018	Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.	ATM
28654064	10.3791/55703	2018	Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay.	ATM
28664939	10.1038/modpathol.2017.58	2018	Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.	ATM
28716242	10.1016/j.jns.2017.06.012	2018	A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis.	ATM
28797244	10.1186/s12885-017-3530-z	2018	A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.	ATM
28950914	10.1186/s13046-017-0601-6	2018	Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.	ATM
29132323	10.1186/s12885-017-3711-9	2018	Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.	ATM
29138385	10.12659/msm.907293	2018	Parameters for Contrast-Enhanced Ultrasound (CEUS) of Enlarged Superficial Lymph Nodes for the Evaluation of Therapeutic Response in Lymphoma: A Preliminary Study.	ATM
29144413	10.3390/v9110341	2018	Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle.	ATM
29179029	10.1016/j.leukres.2017.08.007	2018	3EZ, 20Ac-ingenol induces cell-specific apoptosis in cyclin D1 over-expression through the activation of ATR and downregulation of p-Akt.	ATM
29298131	10.1080/13510002.2017.1416773	2018	A systematic review of p53 regulation of oxidative stress in skeletal muscle.	ATM
29311308	10.1073/pnas.1719988115	2018	DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions.	ATM
29534356	10.3760/cma.j.issn.0529-5807.2018.03.006	2018	[Clinicopathologic characteristics of Burkitt-like lymphoma with chromosome 11q aberration].	ATM
26657151	10.1038/onc.2015.456	2017	Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.	ATM
26976752	10.1016/j.exphem.2016.03.001	2017	Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study.	ATM
26980288	10.3109/10428194.2016.1157871	2017	Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells.	ATM
27121473	10.1182/blood-2016-02-699843	2017	Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.	ATM
27164089	10.3390/ijms17050683	2017	Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.	ATM
27235137	10.1182/blood-2016-02-700328	2017	Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.	ATM
27258263	10.3390/ijms17060854	2017	Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus.	ATM
27304073	10.7554/eLife.14709	2017	Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors.	ATM
27407063	10.1002/ijc.30263	2017	Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.	ATM
27488684	10.1080/14656566.2016.1217992	2017	Targeting deficient DNA damage repair in gastric cancer.	ATM
27499002	10.1080/10428194.2016.1213829	2017	Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.	ATM
27559048	10.4049/jimmunol.1501989	2017	The DNA Damage Response Regulates RAG1/2 Expression in Pre-B Cells through ATM-FOXO1 Signaling.	ATM
27581360	10.1182/blood-2015-09-672980	2017	Perturbed hematopoiesis in mice lacking ATMIN.	ATM
27605053	10.1007/s00428-016-2016-8	2017	Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.	ATM
27742075	10.1016/j.beha.2016.08.002	2017	TP53 dysfunction in CLL: Implications for prognosis and treatment.	ATM
27857131	10.1038/leu.2016.325	2017	Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma.	ATM
27936980	10.1080/17474086.2017.1270203	2017	Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.	ATM
28032863	10.1038/cddis.2016.425	2017	Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.	ATM
28095352	10.1016/j.leukres.2017.01.001	2017	The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.	ATM
28196983	10.1038/leu.2017.55	2017	Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.	ATM
28249048	10.1371/journal.ppat.1006249	2017	Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells.	ATM
28302137	10.1186/s13045-017-0438-7	2017	Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.	ATM
28418119	10.1111/cas.13260	2017	Endoplasmic reticulum stress pathway PERK-eIF2α confers radioresistance in oropharyngeal carcinoma by activating NF-κB.	ATM
28419429	10.1111/bjh.14633	2017	Mutational landscape of B-cell post-transplant lymphoproliferative disorders.	ATM
28479198	10.1016/j.bmcl.2017.04.026	2017	Sulfoximines as ATR inhibitors: Analogs of VE-821.	ATM
28488180	10.1007/s00251-017-0983-9	2017	A new ataxia-telangiectasia mutation in an 11-year-old female.	ATM
28544233	10.1111/cas.13283	2017	Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response.	ATM
28648892	10.1016/j.dnarep.2017.06.022	2017	ASCIZ/ATMIN is dispensable for ATM signaling in response to replication stress.	ATM
24144307	10.3109/10428194.2013.856007	2016	The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan.	ATM
24935205	10.1111/ejh.12400	2016	Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation.	ATM
25023849	10.1016/j.medcli.2014.04.025	2016	[Mantle cell lymphoma: Towards a personalized therapeutic strategy?].	ATM
25143154	10.1002/hon.2160	2016	PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage.	ATM
25827173	10.3109/10428194.2015.1034701	2016	NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.	ATM
25950714	10.1371/journal.pone.0126088	2016	DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.	ATM
25960206	10.1002/gcc.22253	2016	NFkB is activated by multiple mechanisms in hairy cell leukemia.	ATM
26061708	10.18632/oncotarget.4093	2016	rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis.	ATM
26104798	10.1186/s12885-015-1489-1	2016	Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.	ATM
26205622	10.1111/bjh.13613	2016	Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.	ATM
26219558	10.1186/s13045-015-0191-8	2016	Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas.	ATM
26247737	10.1038/cddis.2015.223	2016	Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.	ATM
26310626	10.1093/hmg/ddv342	2016	A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.	ATM
26312880	10.1016/S0140-6736(15)60373-7	2016	Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway.	ATM
26338274	10.1038/leu.2015.241	2016	The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells.	ATM
26400962	10.1182/blood-2015-06-654749	2016	ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.	ATM
26498208	10.1016/j.mrfmmm.2015.10.001	2016	Microsatellite instability detected in tumor-related genes in C57BL/6J mice with thymic lymphoma induced by N-methyl-N-nitrosourea.	ATM
26536348	10.1371/journal.pone.0141906	2016	Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.	ATM
26538284	10.1158/1541-7786.MCR-15-0281	2016	Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model.	ATM
26743341	10.1016/j.bbmt.2015.12.022	2016	Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.	ATM
26771713	10.1080/15384101.2015.1121322	2016	BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair.	ATM
26774591	10.1016/j.clim.2016.01.002	2016	Next generation sequencing revealed DNA ligase IV deficiency in a developmentally normal patient with massive brain Epstein-Barr virus-positive diffuse large B-cell lymphoma.	ATM
26801745	10.1016/j.canlet.2016.01.007	2016	Uridine homeostatic disorder leads to DNA damage and tumorigenesis.	ATM
26855947	10.3978/j.issn.2305-5839.2015.12.59	2016	Childhood colon cancer in a patient with ataxia telangiectasia.	ATM
27127767	10.21037/atm.2016.03.30	2016	Pathology analysis of a rare case of diffuse pulmonary lymphangiomatosis.	ATM
27294099	10.21037/atm.2016.05.30	2016	SarcoMiR friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy.	ATM
27656146	10.3389/fphar.2016.00301	2016	Protective Effect of Cyanidin-3-O-Glucoside against Ultraviolet B Radiation-Induced Cell Damage in Human HaCaT Keratinocytes.	ATM
23906020	10.3109/10428194.2013.829919	2015	The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.	ATM
24457012	10.1016/j.semcancer.2014.01.002	2015	Regulation of the latent-lytic switch in Epstein-Barr virus.	ATM
24663073	10.1097/MPH.0000000000000151	2015	T-cell ALL in ataxia telangiectasia cured with only 7 weeks of anti-leukemic therapy.	ATM
24732096	10.4161/cc.28707	2015	BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response.	ATM
24800916	10.1007/s10549-014-2971-1	2015	Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.	ATM
24841718	10.4161/cc.29212	2015	Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.	ATM
24852242	10.1016/j.anndiagpath.2014.03.006	2015	Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and/or 13q14.	ATM
24857884	10.1097/MOH.0000000000000057	2015	Do mantle cell lymphomas have an 'Achilles heel'?	ATM
24913718	10.1158/2326-6066.CIR-14-0090	2015	Mechanisms that can promote peripheral B-cell lymphoma in ATM-deficient mice.	ATM
25009785	10.1016/j.redox.2014.02.008	2015	Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage.	ATM
25010664	10.1371/journal.pone.0101685	2015	Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.	ATM
25132270	10.1038/onc.2014.248	2015	CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress.	ATM
25232030	10.1158/1541-7786.MCR-14-0240	2015	A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.	ATM
25371178	10.1038/leu.2014.318	2015	The impact of SF3B1 mutations in CLL on the DNA-damage response.	ATM
25444907	10.1016/j.canlet.2014.11.024	2015	Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.	ATM
25486566	10.4161/15384101.2014.949144	2015	Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.	ATM
25488969	10.1200/JCO.2014.56.5101	2015	Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies.	ATM
25659036	10.4161/15384101.2014.988020	2015	Somatic inactivation of ATM in hematopoietic cells predisposes mice to cyclin D3 dependent T cell acute lymphoblastic leukemia.	ATM
25676421	10.1038/leu.2015.41	2015	Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.	ATM
25721125	10.1182/blood-2015-01-622621	2015	Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency.	ATM
25938254	10.3791/52599	2015	Utilizing murine inducible telomerase alleles in the studies of tissue degeneration/regeneration and cancer.	ATM
25964588		2015	Rare Complex Mutational Profile in an ALK Inhibitor-resistant Non-small Cell Lung Cancer.	ATM
26022239	10.1182/blood-2015-02-628792	2015	High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.	ATM
26189108	10.1016/j.leukres.2015.06.005	2015	Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.	ATM
26535076	10.4062/biomolther.2015.085	2015	Pretreatment with Lycopene Attenuates Oxidative Stress-Induced Apoptosis in Human Mesenchymal Stem Cells.	ATM
22282239	10.1007/s11596-012-0003-0	2014	PI3K-like kinases restrain Pim gene expression in endothelial cells.	ATM
23117293	10.3892/or.2012.2091	2014	Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation.	ATM
23318439	10.1038/onc.2012.577	2014	ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis.	ATM
23509889	10.3109/08880018.2013.777949	2014	Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant.	ATM
23614766	10.3109/10428194.2013.796058	2014	Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia.	ATM
23761041	10.1126/scitranslmed.3005814	2014	Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.	ATM
23808769	10.3109/10428194.2013.796056	2014	The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells.	ATM
23820165	10.4142/jvs.2013.14.3.271	2014	Differential expression of thymic DNA repair genes in low-dose-rate irradiated AKR/J mice.	ATM
23858098	10.1158/1541-7786.MCR-13-0252-T	2014	53BP1 is limiting for NHEJ repair in ATM-deficient model systems that are subjected to oncogenic stress or radiation.	ATM
23900513	10.1038/ncomms3231	2014	The RAG2 C-terminus and ATM protect genome integrity by controlling antigen receptor gene cleavage.	ATM
24090759	10.1016/j.jns.2013.09.014	2014	Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.	ATM
24248351	10.1073/pnas.1311947110	2014	Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice.	ATM
24272086	10.1007/s13277-013-1421-8	2014	Detection and clinical significance of genes in primary gastrointestinal MALT lymphoma.	ATM
24281971	10.1002/pbc.24884	2014	CLL/SLL diagnosed in an adolescent.	ATM
24413734	10.1038/ng.2873	2014	Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.	ATM
24474198	10.1007/s13238-013-0017-9	2014	Gadd45a deletion aggravates hematopoietic stem cell dysfunction in ATM-deficient mice.	ATM
24484210	10.2174/18715230113129990016	2014	Beta caryophyllene and caryophyllene oxide, isolated from Aegle marmelos, as the potent anti-inflammatory agents against lymphoma and neuroblastoma cells.	ATM
24486595	10.1158/1078-0432.CCR-13-2707	2014	Combination of YM155, a survivin suppressant, with bendamustine and rituximab: a new combination therapy to treat relapsed/refractory diffuse large B-cell lymphoma.	ATM
24498068	10.1371/journal.pone.0087299	2014	Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest.	ATM
24682267	10.1182/blood-2013-07-517177	2014	The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.	ATM
24690081	10.1111/bjh.12851	2014	Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.	ATM
24709420	10.1593/neo.131980	2014	Strain background determines lymphoma incidence in Atm knockout mice.	ATM
24729610	10.4049/jimmunol.1303481	2014	ATM increases activation-induced cytidine deaminase activity at downstream S regions during class-switch recombination.	ATM
24982162	10.1073/pnas.1410112111	2014	Developmental propagation of V(D)J recombination-associated DNA breaks and translocations in mature B cells via dicentric chromosomes.	ATM
25079327	10.1038/nature13483	2014	DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier.	ATM
22170260	10.1002/hon.1020	2013	Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.	ATM
22369572	10.3109/10428194.2012.668683	2013	Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.	ATM
22646928	10.3109/10428194.2012.698278	2013	Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.	ATM
22967417		2013	[Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].	ATM
23011031	10.1038/mt.2012.203	2013	Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia.	ATM
23015717	10.1128/JVI.01850-12	2013	The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli.	ATM
23089009	10.1016/j.icrp.2012.06.030	2013	Genetic predisposition to radiation-related cancer and potential implications for risk assessment.	ATM
23100326	10.1093/hmg/dds448	2013	Bone marrow transplantation improves the outcome of Atm-deficient mice through the migration of ATM-competent cells.	ATM
23369149	10.1186/1755-8166-6-5	2013	Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.	ATM
23383325	10.1371/journal.pone.0055361	2013	Rad9, Rad17, TopBP1 and claspin play essential roles in heat-induced activation of ATR kinase and heat tolerance.	ATM
23403624	10.1182/blood-2012-08-446096	2013	Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.	ATM
23407552	10.1182/blood-2013-01-478834	2013	The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.	ATM
23440662	10.1002/ajh.23380	2013	Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components.	ATM
23848026		2013	[Acute transverse myelitis after allogeneic bone marrow transplantation for acute lymphoblastic leukemia--a case report].	ATM
23941244	10.1089/dna.2013.2138	2013	Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.	ATM
24145436	10.1073/pnas.1314608110	2013	Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.	ATM
21765465	10.1038/onc.2011.303	2012	Absence of Wip1 partially rescues Atm deficiency phenotypes in mice.	ATM
21767243	10.3109/10428194.2011.606384	2012	Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.	ATM
21874232	10.3892/ijo.2011.1170	2012	Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.	ATM
21933891	10.1158/1078-0432.CCR-11-1198	2012	Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells.	ATM
21980358	10.1371/journal.pone.0024813	2012	Loss of p53 Ser18 and Atm results in embryonic lethality without cooperation in tumorigenesis.	ATM
22017321	10.1111/j.1440-1789.2011.01263.x	2012	Neuropathology in classical and variant ataxia-telangiectasia.	ATM
22023519	10.3109/10428194.2011.631638	2012	Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.	ATM
22023523	10.3109/10428194.2011.634043	2012	Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines.	ATM
22030621	10.4161/cc.10.20.17887	2012	Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition.	ATM
22065599	10.1182/blood-2011-08-374561	2012	Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.	ATM
22144182	10.1182/blood-2011-08-373639	2012	Mitochondrial dysfunction in ataxia-telangiectasia.	ATM
22149137	10.3109/10428194.2011.647310	2012	The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease.	ATM
22204453	10.3109/10428194.2011.653640	2012	No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.	ATM
22210878	10.1182/blood-2011-11-391474	2012	Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.	ATM
22280536	10.3109/10428194.2012.660630	2012	Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.	ATM
22301699	10.1038/modpathol.2011.213	2012	Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.	ATM
22312109	10.1084/jem.20110325	2012	Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis.	ATM
22341440	10.1016/j.cell.2011.12.028	2012	Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.	ATM
22416035	10.1002/emmm.201200229	2012	Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.	ATM
22483155	10.2174/156800912800673211	2012	Novel and emerging drugs for rarer chronic lymphoid leukaemias.	ATM
22558013	10.4103/1817-1737.94527	2012	Combined use of EUS-guided FNA and immunocytochemical stains discloses metastatic and unusual diseases in the evaluation of mediastinal lymphadenopathy of unknown etiology.	ATM
22687754	10.1016/j.exphem.2012.06.001	2012	Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.	ATM
22709691	10.1182/blood-2012-02-413195	2012	Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM.	ATM
23045915		2012	Safe administration of hyperbaric oxygen after bleomycin: a case series of 15 patients.	ATM
19586936	10.3324/haematol.2009.007526	2011	Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia.	ATM
19641646	10.4103/1817-1737.53354	2011	Clinicopathological analysis and outcome of primary mediastinal malignancies - A report of 91 cases from a single institute.	ATM
20739657	10.1182/blood-2010-01-265769	2011	The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.	ATM
20974981	10.4049/jimmunol.1000618	2011	Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes.	ATM
21176359		2011	[Clinical and biological features of 8 patients with Richter's syndrome].	ATM
21205928	10.1182/blood-2010-05-285999	2011	Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia.	ATM
21209379	10.1182/blood-2010-09-310987	2011	ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes.	ATM
21216954	10.1074/jbc.M110.176354	2011	Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.	ATM
21264165	10.4103/1817-1737.74270	2011	Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation.	ATM
21264167	10.4103/1817-1737.74272	2011	Sarcoidosis in the eastern region of Saudi Arabia.	ATM
21368836	10.1038/nature09755	2011	The RAG2 C terminus suppresses genomic instability and lymphomagenesis.	ATM
21490582	10.3791/2598	2011	Derivation of thymic lymphoma T-cell lines from Atm(-/-) and p53(-/-) mice.	ATM
21526939	10.2217/fmb.11.16	2011	The Ying-Yang of the virus-host interaction: control of the DNA damage response.	ATM
21575860	10.1016/j.ccr.2011.03.022	2011	ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma.	ATM
21577253	10.3389/fneur.2011.00023	2011	Neuroprotective effect of hyperbaric oxygen therapy on anterior ischemic optic neuropathy.	ATM
21644224	10.3760/cma.j.issn.1003-9406.2011.03.010	2011	[Cytogenetic study of mantle cell lymphoma].	ATM
21657959	10.3109/10428194.2011.577256	2011	Patient with ataxia telangiectasia who developed acute myeloid leukemia.	ATM
21665257	10.1016/j.jaci.2011.03.052	2011	Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.	ATM
21706008	10.1038/nsmb.2078	2011	Chfr and RNF8 synergistically regulate ATM activation.	ATM
21792198	10.1038/bjc.2011.266	2011	Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours.	ATM
21878675	10.1182/blood-2010-11-318873	2011	The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.	ATM
21892312	10.4137/cmo.s535	2011	Experimental antioxidant therapy in ataxia telangiectasia.	ATM
16956411	10.1186/1748-717X-1-35	2010	Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.	ATM
18410453	10.1111/j.1365-2141.2008.07124.x	2010	Advances in the understanding of mantle cell lymphoma.	ATM
19404735	10.1007/s10549-009-0396-z	2010	ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.	ATM
19594747	10.1111/j.1365-2141.2009.07791.x	2010	Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.	ATM
19826250	10.1097/PAI.0b013e3181bbd5d5	2010	Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.	ATM
19882354	10.1007/s10495-009-0417-8	2010	Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues.	ATM
19898425	10.1038/modpathol.2009.156	2010	AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations.	ATM
19966290	10.1073/pnas.0908946107	2010	Role of the translocation partner in protection against AID-dependent chromosomal translocations.	ATM
20046894	10.18632/aging.100015	2010	Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas.	ATM
20124459	10.1158/1535-7163.MCT-09-0872	2010	ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors.	ATM
20145032	10.1158/1541-7786.MCR-09-0324	2010	Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.	ATM
20566716	10.1084/jem.20100285	2010	ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.	ATM
20864035	10.1016/j.molcel.2010.08.019	2010	AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling.	ATM
21036702		2010	Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.	ATM
16755915	10.1016/s1872-2075(06)60033-2	2009	[In vitro cytolysis of B-lymphoma cells mediated by an anti-CD3/anti-CD20 bispecific single-chain antibody].	ATM
19000702	10.1016/j.mrfmmm.2008.10.002	2009	Rag-dependent and Rag-independent mechanisms of Notch1 rearrangement in thymic lymphomas of Atm(-/-) and scid mice.	ATM
19067706	10.1111/j.1365-2133.2008.08931.x	2009	Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.	ATM
19347737	10.1080/10428190902763533	2009	Treatment resistance in chronic lymphocytic leukemia: the role of the p53 pathway.	ATM
19364503	10.1016/j.bbrc.2009.04.019	2009	Deregulation of mTOR signaling is involved in thymic lymphoma development in Atm-/- mice.	ATM
19411853	10.4161/cc.8.11.8598	2009	DNA damage response as a biomarker in treatment of leukemias.	ATM
19477219	10.1016/j.exphem.2009.04.012	2009	Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array.	ATM
19514131	10.1016/j.abb.2009.01.018	2009	Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.	ATM
19626507	10.1080/08977190903112663	2009	Growth hormone supplementation increased latency to tumourigenesis in Atm-deficient mice.	ATM
19650357	10.1017/s0317167100007794	2009	Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment.	ATM
19718051	10.1038/onc.2009.258	2009	Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.	ATM
17704807	10.1038/sj.onc.1210718	2008	Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells.	ATM
17932249	10.1182/blood-2007-04-085399	2008	ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.	ATM
18037553	10.1016/j.fct.2007.08.028	2008	Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice.	ATM
18056440	10.1158/0008-5472.CAN-07-1749	2008	Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer.	ATM
18089799	10.1158/0008-5472.CAN-07-1610	2008	The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.	ATM
18097478	10.1172/JCI34503	2008	Antimalarial therapy prevents Myc-induced lymphoma.	ATM
18097482	10.1172/JCI33700	2008	Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.	ATM
18261794	10.1016/j.leukres.2007.12.012	2008	Detection of ATM gene deletion/duplication by multiplex ligation-dependant probe amplification in childhood lymphoid malignancies: a report from the Children's Oncology Group.	ATM
18275429	10.1111/j.1365-2141.2007.06924.x	2008	Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.	ATM
18283338	10.1593/neo.07935	2008	Endoplasmic reticulum stress and unfolded protein response in Atm-deficient thymocytes and thymic lymphoma cells are attributable to oxidative stress.	ATM
18357388		2008	ATR alterations in Hodgkin's lymphoma.	ATM
18583527	10.1158/1541-7786.MCR-07-2009	2008	Tumor suppression by p53 in the absence of Atm.	ATM
18683215	10.1002/cncr.23796	2008	Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival.	ATM
18699851	10.1111/j.1365-2141.2008.07334.x	2008	Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.	ATM
18709664	10.1002/gcc.20609	2008	Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.	ATM
16862178	10.1038/sj.onc.1209815	2007	NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.	ATM
17148591	10.1182/blood-2006-05-020545	2007	Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells.	ATM
17157163	10.1016/j.exphem.2006.07.008	2007	Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.	ATM
17158963	10.1084/jem.20061563	2007	Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.	ATM
17182545	10.4049/jimmunol.178.1.103	2007	Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes.	ATM
17182831	10.1093/jn/137.1.229S	2007	Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice.	ATM
17213020	10.1016/j.cancergencyto.2006.07.010	2007	Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.	ATM
17374122	10.1111/j.1349-7006.2007.00443.x	2007	Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.	ATM
17418878	10.1016/j.steroids.2007.02.004	2007	The glucocorticoid receptor is increased in Atm-/- thymocytes and in Atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression.	ATM
17516749	10.5858/2007-131-457-COAMPE	2007	Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.	ATM
17562874	10.1182/blood-2007-02-075614	2007	The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.	ATM
17563396	10.1200/JCO.2006.08.7999	2007	Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.	ATM
17613764	10.1080/10428190701402903	2007	Characterization of genetic changes in MCL by interphase FISH on tissue sections.	ATM
17634425	10.1158/1541-7786.MCR-07-0058	2007	Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis.	ATM
17640065	10.1002/ijc.22888	2007	A systematic evaluation of the ataxia telangiectasia mutated gene does not show an association with non-Hodgkin lymphoma.	ATM
17664422	10.1073/pnas.0701953104	2007	Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.	ATM
17852707	10.1080/10428190701573224	2007	Promoter hypermethylation of multiple genes in gastric lymphoma.	ATM
17875758	10.1158/1078-0432.CCR-07-0283	2007	ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.	ATM
17876757	10.1002/path.2232	2007	Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation.	ATM
15749671		2006	Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.	ATM
16087685	10.1093/hmg/ddi301	2006	Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas.	ATM
16125772	10.1016/j.leukres.2005.07.012	2006	ATM promoter analysis in childhood lymphoid malignancies: a brief communication.	ATM
16321852	10.1080/10428190500254141	2006	11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.	ATM
16337250	10.1016/j.mrfmmm.2005.10.008	2006	Regulation of radiation-induced protein kinase Cdelta activation in radiation-induced apoptosis differs between radiosensitive and radioresistant mouse thymic lymphoma cell lines.	ATM
16387360	10.1016/j.leukres.2005.11.010	2006	Development of a mantle cell lymphoma in an ATM heterozygous woman after occupational exposure to ionising radiation and somatic mutation of the second allele.	ATM
16408093	10.1038/sj.leu.2404091	2006	ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.	ATM
16427027	10.1016/j.bcp.2005.12.018	2006	Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways.	ATM
16432227	10.1073/pnas.0507367103	2006	ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.	ATM
16434369		2006	Establishment of the MAVER-1 cell line, a model for leukemic and aggressive mantle cell lymphoma.	ATM
16448540	10.1111/j.0105-2896.2006.00361.x	2006	ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis: the DSB connection.	ATM
16461462	10.1073/pnas.0510441103	2006	Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.	ATM
16487171	10.1111/j.1365-2141.2005.05919.x	2006	Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.	ATM
16542220	10.1111/j.1349-7006.2006.00165.x	2006	Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability.	ATM
16631465	10.1016/j.cancergencyto.2005.09.005	2006	ATM alterations in childhood non-Hodgkin lymphoma.	ATM
16753863	10.1080/10428190500513835	2006	New molecular markers in resistant B-CLL.	ATM
16781197	10.1016/j.dnarep.2006.05.003	2006	Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice.	ATM
16863997	10.1016/j.freeradbiomed.2006.05.008	2006	ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state.	ATM
16934538	10.1016/j.dnarep.2006.05.024	2006	Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations.	ATM
16934683	10.1016/j.freeradbiomed.2006.06.018	2006	Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant.	ATM
15632067	10.1128/MCB.25.2.661-670.2005	2005	Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.	ATM
15744354	10.1038/sj.leu.2403676	2005	Absence of ATM hypermethylation in mantle cell and follicular lymphoma.	ATM
15767564	10.1073/pnas.0500830102	2005	A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.	ATM
15965466	10.1038/ncb1276	2005	Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation.	ATM
15965469	10.1038/ncb1270	2005	Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models.	ATM
15973455	10.1038/sj.leu.2403841	2005	Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas.	ATM
16053658	10.1097/00130404-200505000-00001	2005	Richter's syndrome: biology and therapy.	ATM
16150740	10.1093/hmg/ddi324	2005	Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.	ATM
16155021	10.1200/JCO.2005.05.019	2005	Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.	ATM
16167060	10.1038/sj.leu.2403943	2005	Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.	ATM
12969974	10.1182/blood-2003-01-0094	2004	Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease.	ATM
14628072	10.1038/sj.leu.2403221	2004	ATM gene and lymphoid malignancies.	ATM
14735203	10.1038/sj.bjc.6601522	2004	Molecular variants of the ATM gene in Hodgkin's disease in children.	ATM
12473594		2003	Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.	ATM
12511424	10.1182/blood-2002-02-0570	2003	Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement.	ATM
12513844		2003	[ATM and Cancer].	ATM
12875964	10.1016/S0002-9440(10)63672-3	2003	Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias.	ATM
12036888	10.1182/blood.v99.12.4554	2002	Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.	ATM
12149228	10.1182/blood-2002-02-0382	2002	ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.	ATM
10706620	10.1073/pnas.050400997	2000	Mantle cell lymphoma is characterized by inactivation of the ATM gene.	ATM
10397742		1999	Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.	ATM
9463314	10.1086/301706	1998	ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.	ATM
8789452	10.1093/hmg/5.1.145	1996	Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia.	ATM
